標(biāo)題: Titlebook: Bio-Nanomedicine for Cancer Therapy; Flavia Fontana,Hélder A. Santos Book 2021 The Editor(s) (if applicable) and The Author(s), under excl [打印本頁] 作者: Espionage 時間: 2025-3-21 19:33
書目名稱Bio-Nanomedicine for Cancer Therapy影響因子(影響力)
書目名稱Bio-Nanomedicine for Cancer Therapy影響因子(影響力)學(xué)科排名
書目名稱Bio-Nanomedicine for Cancer Therapy網(wǎng)絡(luò)公開度
書目名稱Bio-Nanomedicine for Cancer Therapy網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Bio-Nanomedicine for Cancer Therapy被引頻次
書目名稱Bio-Nanomedicine for Cancer Therapy被引頻次學(xué)科排名
書目名稱Bio-Nanomedicine for Cancer Therapy年度引用
書目名稱Bio-Nanomedicine for Cancer Therapy年度引用學(xué)科排名
書目名稱Bio-Nanomedicine for Cancer Therapy讀者反饋
書目名稱Bio-Nanomedicine for Cancer Therapy讀者反饋學(xué)科排名
作者: Outwit 時間: 2025-3-21 21:39 作者: 厭煩 時間: 2025-3-22 04:27
,Beobachtungen an V?geln und Insekten,new research hotspot. While a great deal of progress has been made in this direction and preclinical results report many different kinds of promising multifunctional smart nanomedicine, the design of these intelligent nanomedicines is often too complicated, the requirements for the preparation proce作者: MIR 時間: 2025-3-22 05:30 作者: 歌唱隊(duì) 時間: 2025-3-22 12:01
Grossh. Hessischen Versuchsanstaltsite. Moreover, cancer cell membranes serve as sources of neoantigens, useful in the formulation of nanovaccines. In this chapter, we will discuss the advantages of biohybrid nanosystems in cancer chemotherapy, immunotherapy, and combined therapy, as well as highlight their preparation methods and c作者: MURAL 時間: 2025-3-22 14:20
https://doi.org/10.1007/978-3-662-33929-9nsors can detect individual vesicles inside the cytoplasm, delineate tumor margins based on intracellular enzyme activity, and measure changes in cell metabolism almost in real time. While most of these applications are currently in the proof-of-concept stage, nanoneedle technology is poised to offe作者: Ethics 時間: 2025-3-22 17:06 作者: 使閉塞 時間: 2025-3-22 23:51 作者: syring 時間: 2025-3-23 02:58
Grossh. Hessischen Versuchsanstaltsing tools for more accurately assessing nanoparticle activity, owing to their ability to recapitulate certain features of the tumor microenvironment and thus provide mechanistic insights into nanocarrier intratumoral penetration and diffusion rates..Notwithstanding, in vivo validation of nanomedici作者: 彩色的蠟筆 時間: 2025-3-23 07:09
Bergtod eines verdienten Mitarbeiters,gradation, sustain and control the release for the entrapped cargo, and enhance the immune responses..Several studies reported that different physical characteristics of nanoparticles affect their uptake in cells and the potential to induce cellular responses. Among them, particle size and surface c作者: 滲入 時間: 2025-3-23 10:03
Bergtod eines verdienten Mitarbeiters,al genomic depletion would turn the normal tropism of viruses to conditionally replicate in cancer cells only. This category of viruses, named ‘Oncolytic viruses’, have been investigated and used for cancer treatment in the past decades resulting in the approval of the first oncolytic virus, a herpe作者: 孤僻 時間: 2025-3-23 14:15 作者: 擺動 時間: 2025-3-23 20:33
Boosting Nanomedicine Efficacy with Hyperbaric Oxygen Therapynew research hotspot. While a great deal of progress has been made in this direction and preclinical results report many different kinds of promising multifunctional smart nanomedicine, the design of these intelligent nanomedicines is often too complicated, the requirements for the preparation proce作者: mutineer 時間: 2025-3-23 22:47 作者: agonist 時間: 2025-3-24 05:27
Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worldssite. Moreover, cancer cell membranes serve as sources of neoantigens, useful in the formulation of nanovaccines. In this chapter, we will discuss the advantages of biohybrid nanosystems in cancer chemotherapy, immunotherapy, and combined therapy, as well as highlight their preparation methods and c作者: vertebrate 時間: 2025-3-24 07:38
Nanoneedle-Based Materials for Intracellular Studiesnsors can detect individual vesicles inside the cytoplasm, delineate tumor margins based on intracellular enzyme activity, and measure changes in cell metabolism almost in real time. While most of these applications are currently in the proof-of-concept stage, nanoneedle technology is poised to offe作者: 勤勉 時間: 2025-3-24 13:31 作者: Acupressure 時間: 2025-3-24 17:54
3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticlesfferences or the interaction between several cell populations may contribute to different tumor response to the treatment. Also, different types of nanoparticles may have different behavior in 3D models, depending on their nature, physicochemical properties, the presence of targeting ligands on the 作者: EXCEL 時間: 2025-3-24 19:12 作者: 牛的細(xì)微差別 時間: 2025-3-25 01:23
Nanotechnology for the Development of Nanovaccines in Cancer Immunotherapygradation, sustain and control the release for the entrapped cargo, and enhance the immune responses..Several studies reported that different physical characteristics of nanoparticles affect their uptake in cells and the potential to induce cellular responses. Among them, particle size and surface c作者: 條街道往前推 時間: 2025-3-25 05:14
Viral Nanoparticles: Cancer Vaccines and Immune Modulatorsal genomic depletion would turn the normal tropism of viruses to conditionally replicate in cancer cells only. This category of viruses, named ‘Oncolytic viruses’, have been investigated and used for cancer treatment in the past decades resulting in the approval of the first oncolytic virus, a herpe作者: bioavailability 時間: 2025-3-25 11:09
https://doi.org/10.1007/978-3-030-58174-9Biohybrid; Nanotechnology; Cancer nanotechnology; Vaccines nantechnology; Drug delivery systems nanotech作者: Preamble 時間: 2025-3-25 14:59
978-3-030-58176-3The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: Esalate 時間: 2025-3-25 18:43 作者: 思想上升 時間: 2025-3-25 23:50
https://doi.org/10.1007/978-3-662-33931-2 reduce accumulation at nontarget sites. Here, we describe current approaches for tumor-homing peptide identification and validation, and provide comprehensive overview of classes of tumor-homing peptides undergoing preclinical and clinical development. We focus on unique mechanistic features and ap作者: Musket 時間: 2025-3-26 01:59
,Beobachtungen an V?geln und Insekten,drawbacks of conventional treatments and improve the therapeutic outcome in many diseases, especially cancer. Nanoparticle vectors have demonstrated the potential to concomitantly deliver diagnostic and therapeutic payloads to diseased tissue. Due to their special physical and chemical properties, t作者: palette 時間: 2025-3-26 05:29 作者: Prostatism 時間: 2025-3-26 11:10 作者: FLIT 時間: 2025-3-26 16:02 作者: Outwit 時間: 2025-3-26 19:39 作者: 疏忽 時間: 2025-3-26 22:57
Grossh. Hessischen Versuchsanstaltaffolds present some remarkable features including high loading capacity and encapsulation efficiency, superficial area and porosity, potential for modification, structure for the co-delivery of various therapies, and cost-effectiveness. Their present and future applications for cancer diagnosis and作者: 刺耳的聲音 時間: 2025-3-27 04:22 作者: REIGN 時間: 2025-3-27 05:34 作者: Precursor 時間: 2025-3-27 10:07
,Beobachtungen an V?geln und Insekten,s tumor spheroids, are more representing the natural tumor microenvironment. They have been shown to have higher invasiveness and resistance to cytotoxic agents and radiotherapy compared to cells growing in 2D monolayer. Furthermore, to improve the prediction of clinical efficacy of drugs, in the pa作者: SKIFF 時間: 2025-3-27 15:35 作者: Prostaglandins 時間: 2025-3-27 19:59
Bergtod eines verdienten Mitarbeiters,ciated with severe side effects due to toxicity on normal cells. Consequently, there is an urgent need for novel therapeutic approaches that are able to effectively and selectively target tumor cells without any adverse effects on normal cells. Among the new approaches, cancer immunotherapy seems pr作者: 確保 時間: 2025-3-28 00:58 作者: Pessary 時間: 2025-3-28 03:21
Bergtod eines verdienten Mitarbeiters,m an expanded landscape of treatment options for several tumour types. The value of cancer immunotherapy is well-established thanks to the clinical success following regulatory approval of several immunomodulators and cellular immunotherapies, and both the private and the public sector are investing作者: 波動 時間: 2025-3-28 06:59
Bio-Nanomedicine for Cancer Therapy978-3-030-58174-9Series ISSN 0065-2598 Series E-ISSN 2214-8019 作者: oracle 時間: 2025-3-28 12:37 作者: ADORN 時間: 2025-3-28 15:21 作者: 易受刺激 時間: 2025-3-28 18:55
Conventional Nanosized Drug Delivery Systems for Cancer Applicationsart drug delivery systems (DDSs) with stimuli-responsive properties and novel materials have been developed. Several clinical trials demonstrated that these DDSs have better clinical therapeutic efficacy in the treatment of many cancers than free drugs. Composition of DDSs and their surface properti作者: 苦惱 時間: 2025-3-29 02:09 作者: 壯麗的去 時間: 2025-3-29 04:25 作者: Mangle 時間: 2025-3-29 09:54 作者: 絆住 時間: 2025-3-29 12:58 作者: DUST 時間: 2025-3-29 15:53 作者: FACT 時間: 2025-3-29 21:52
Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worldsveral passively targeted nanosystems resulted in improved quality of care for patients. However, the therapeutic efficacy of these systems is not superior to the original drugs. Moreover, despite extensive investigations into actively targeted nanocarriers, numerous barriers still remain before thei作者: negligence 時間: 2025-3-30 03:13 作者: Stable-Angina 時間: 2025-3-30 04:27
Nanoneedle-Based Materials for Intracellular Studies of living cells. Their nanoscale dimensions mean that they are able to penetrate the plasma membrane with minimal disruption of normal cellular functions, allowing researchers to probe the intracellular space and deliver or extract material from individual cells. In the last decade, a variety of st作者: Outspoken 時間: 2025-3-30 10:35
In Vitro Assays for Nanoparticle—Cancer Cell Interaction Studiesl translation is still scarce. One of the main hurdles contributing for this setback is the lack of reliable in vitro models for preclinical testing capable of predicting the outcomes in an in vivo setting. In fact, the use of 2D monolayers, considered the gold-standard in vitro technique, leads to 作者: 難取悅 時間: 2025-3-30 13:31
3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticless tumor spheroids, are more representing the natural tumor microenvironment. They have been shown to have higher invasiveness and resistance to cytotoxic agents and radiotherapy compared to cells growing in 2D monolayer. Furthermore, to improve the prediction of clinical efficacy of drugs, in the pa作者: 能量守恒 時間: 2025-3-30 18:34 作者: CRP743 時間: 2025-3-30 23:45 作者: grotto 時間: 2025-3-31 04:54
Viral Nanoparticles: Cancer Vaccines and Immune Modulatorsstem and the tumour microenvironment. Those pathogens have naturally evolved and been evolutionary to specifically infect hosts, replicate, deliver their genome, and spread. These properties, initially considered a disadvantage, have been investigated and edited to turn viruses into precious allies 作者: 公司 時間: 2025-3-31 06:02
